J Korean Med Sci.  2016 Jul;31(7):1069-1074. 10.3346/jkms.2016.31.7.1069.

Effects of Educational Interventions for Chronic Airway Disease on Primary Care

• Lee JY
• Yoo KH
• Kim DK
• Kim SH
• Kim TE
• Kim TH
• Rhee CK
• Park YB
• Yoon HK
• Yum HK

• KMID: 2373725
• DOI: http://doi.org/10.3346/jkms.2016.31.7.1069

Abstract

Education has been known to essential for management of chronic airway diseases. However the real benefits remain unclear. We evaluated the effectiveness of an organized educational intervention for chronic airway diseases directed at primary care physicians and patients. The intervention was a 1-month education program of three visits, during which subjects were taught about their disease, an action plan in acute exacerbation and inhaler technique. Asthma control tests (ACT) for asthma and, chronic obstructive pulmonary disease (COPD) assessment tests (CAT) for COPD subjects were compared before and after education as an index of quality of life. Educational effectiveness was also measured associated with improvement of their knowledge for chronic airway disease itself, proper use of inhaler technique, and satisfaction of the subjects and clinicians before and after education. Among the 285 participants, 60.7% (n = 173) were men and the mean age was 62.2 ± 14.7. ACT for asthma and CAT in COPD patients were significantly improved by 49.7% (n = 79) and 51.2% (n = 65) more than MCID respectively after education (P < 0.05). In all individual items, knowledge about their disease, inhaler use and satisfaction of the patients and clinicians were also improved after education (P < 0.05). This study demonstrates the well-organized education program for primary care physicians and patients is a crucial process for management of chronic airway diseases.

Keyword

Education; Inhaler; Asthma; Pulmonary Disease, Chronic Obstructive; Physicians, Primary Care

MeSH Terms

Adult
Aged
Aged, 80 and over
Asthma/pathology
Disease Management
Female
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Nebulizers and Vaporizers
*Patient Education as Topic
Patient Satisfaction
Primary Health Care
Pulmonary Disease, Chronic Obstructive/*pathology
Quality of Life
Respiration
Young Adult

Reference

1. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008; 3:371–384.

2. The Global Asthma Network. The global asthma report 2014 [Internet]. accessed on July 2014. Available at http://www.globalasthmareport.org/resources/Global_Asthma_Report_2014.pdf.

3. World Health Organization. Chronic respiratory diseases [Internet]. accessed on 26 February 2008. Available at http://www.who.int/gard/publications/chronic_respiratory_diseases.pdf.

4. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, Yoon HI, Lim SC, Park JY, Park SJ, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011; 16:659–665.

5. Cho SH, Park HW, Rosenberg DM. The current status of asthma in Korea. J Korean Med Sci. 2006; 21:181–187.

6. The Global Initiative for Asthma. Global strategy for asthma management and prevention [Internet]. accessed on 19 May 2015. Available at http://www.ginasthma.com.

7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. accessed on 21 February 2011. Available at http://www.goldcopd.org.

8. Hartert TV, Togias A, Mellen BG, Mitchel EF, Snowden MS, Griffin MR. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Am Geriatr Soc. 2000; 48:651–657.

9. Health Insurance Review and Assessment Service [Internet]. accessed on 3 May 2015. Available at http://www.hira.or.kr.

10. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343:332–336.

11. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 2000; 117:542–550.

12. Cloutier MM, Schatz M, Castro M, Clark N, Kelly HW, Mangione-Smith R, Sheller J, Sorkness C, Stoloff S, Gergen P. Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol. 2012; 129:S24–33.

13. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014; 2:195–203.

14. Kim C, Yoo KH, Rhee CK, Yoon HK, Kim YS, Lee SW, Oh YM, Lee SD, Lee JH, Kim KJ, et al. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea. Int J Tuberc Lung Dis. 2014; 18:737–743.

15. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010; 5:435–444.

16. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med. 2005; 171:109–114.

17. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011; 365:1184–1192.

18. Zainudin BM, Lai CK, Soriano JB, Jia-Horng W, De Guia TS, Asthma I; Asthma Insights and Reality in Asia-Pacific (AIRIAP) Steering Committee. Asthma control in adults in Asia-Pacific. Respirology. 2005; 10:579–586.

19. Chan-Yeung M, Aït-Khaled N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis. 2004; 8:2–14.

20. Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, van Aalderen WM, Price D. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013; 107:1817–1821.

21. Crane MA, Jenkins CR, Goeman DP, Douglass JA. Inhaler device technique can be improved in older adults through tailored education: findings from a randomised controlled trial. NPJ Prim Care Respir Med. 2014; 24:14034.

22. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008; 102:593–604.

23. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003; 16:249–254.

24. Newman SP. Dry powder inhalers for optimal drug delivery. Expert Opin Biol Ther. 2004; 4:23–33.

25. Lee JK, Yang YH. Evaluation of an education program for patients with asthma who use inhalers. J Korean Acad Nurs. 2010; 40:202–212.

26. Kim SH, Cho SH. Educational and decision-support tools for asthma-management guideline implementation. Asia Pac Allergy. 2012; 2:26–34.

27. Choi JY, Cho Chung HI. Effect of an individualised education programme on asthma control, inhaler use skill, asthma knowledge and health-related quality of life among poorly compliant Korean adult patients with asthma. J Clin Nurs. 2011; 20:119–126.

28. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol. 2007; 7:30.

29. Fox NS, Brennan JS, Chasen ST. Clinical estimation of fetal weight and the Hawthorne effect. Eur J Obstet Gynecol Reprod Biol. 2008; 141:111–114.